These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23085102)

  • 1. Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.
    Daniels-Wells TR; Helguera G; Rodríguez JA; Leoh LS; Erb MA; Diamante G; Casero D; Pellegrini M; Martínez-Maza O; Penichet ML
    Toxicol In Vitro; 2013 Feb; 27(1):220-31. PubMed ID: 23085102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.
    Daniels TR; Ng PP; Delgado T; Lynch MR; Schiller G; Helguera G; Penichet ML
    Mol Cancer Ther; 2007 Nov; 6(11):2995-3008. PubMed ID: 18025284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.
    Daniels-Wells TR; Widney DP; Leoh LS; Martínez-Maza O; Penichet ML
    J Immunother; 2015 Oct; 38(8):307-10. PubMed ID: 26325374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.
    Suzuki E; Daniels TR; Helguera G; Penichet ML; Umezawa K; Bonavida B
    Int J Oncol; 2010 May; 36(5):1299-307. PubMed ID: 20372806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
    Daniels TR; Ortiz-Sánchez E; Luria-Pérez R; Quintero R; Helguera G; Bonavida B; Martínez-Maza O; Penichet ML
    J Immunother; 2011; 34(6):500-8. PubMed ID: 21654517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.
    Leoh LS; Morizono K; Kershaw KM; Chen IS; Penichet ML; Daniels-Wells TR
    J Gene Med; 2014; 16(1-2):11-27. PubMed ID: 24436117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
    Rodríguez JA; Luria-Pérez R; López-Valdés HE; Casero D; Daniels TR; Patel S; Avila D; Leuchter R; So S; Ortiz-Sánchez E; Bonavida B; Martínez-Maza O; Charles AC; Pellegrini M; Helguera G; Penichet ML
    Leuk Lymphoma; 2011 Nov; 52(11):2169-78. PubMed ID: 21870996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.
    Leoh LS; Kim YK; Candelaria PV; Martínez-Maza O; Daniels-Wells TR; Penichet ML
    J Immunol; 2018 May; 200(10):3485-3494. PubMed ID: 29654211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.
    Leoh LS; Daniels-Wells TR; Martínez-Maza O; Penichet ML
    Mol Immunol; 2015 Oct; 67(2 Pt B):407-15. PubMed ID: 26232328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV
    Martínez LE; Daniels-Wells TR; Guo Y; Magpantay LI; Candelaria PV; Penichet ML; Martínez-Maza O; Epeldegui M
    Mol Cancer Ther; 2021 Sep; 20(9):1592-1602. PubMed ID: 34158342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.
    Rodríguez JA; Helguera G; Daniels TR; Neacato II; López-Valdés HE; Charles AC; Penichet ML
    J Control Release; 2007 Dec; 124(1-2):35-42. PubMed ID: 17884229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
    Ng PP; Helguera G; Daniels TR; Lomas SZ; Rodriguez JA; Schiller G; Bonavida B; Morrison SL; Penichet ML
    Blood; 2006 Oct; 108(8):2745-54. PubMed ID: 16804109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.
    Daniels-Wells TR; Candelaria PV; Leoh LS; Nava M; Martínez-Maza O; Penichet ML
    J Immunother; 2020; 43(2):48-52. PubMed ID: 31693515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
    Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie MJ; Merlini G; Cazzola M
    Br J Haematol; 1996 Jun; 93(4):789-94. PubMed ID: 8703804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
    Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F
    Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.
    Gosselaar PH; van-Dijk AJ; de-Gast GC; Polito L; Bolognesi A; Vooijs WC; Verheul AF; Krouwer HG; Marx JJ
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():61-9. PubMed ID: 11886434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioinspired pseudopeptide-based intracellular delivery platform enhances the cytotoxicity of a ribosome-inactivating protein through multiple death pathways.
    Morrison G; Henry N; Kopytynski M; Chen R
    Biomater Sci; 2024 Sep; 12(19):5010-5022. PubMed ID: 39177215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species.
    Ortiz-Sánchez E; Daniels TR; Helguera G; Martinez-Maza O; Bonavida B; Penichet ML
    Leukemia; 2009 Jan; 23(1):59-70. PubMed ID: 18946492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320.
    Quadros EV; Nakayama Y; Sequeira JM
    Mol Cancer Ther; 2010 Nov; 9(11):3033-40. PubMed ID: 20858723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.